Gabelli Funds’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.18M | Buy |
73,750
+250
| +0.3% | +$10.8K | 0.02% | 611 |
|
|
2025
Q1 | $2.54M | Hold |
73,500
| – | – | 0.02% | 602 |
|
|
2024
Q4 | $2.02M | Buy |
+73,500
| New | +$2.02M | 0.02% | 650 |
|
|
2021
Q4 | – | Sell |
-6,000
| Closed | -$281K | – | 1432 |
|
|
2021
Q3 | $281K | Sell |
6,000
-2,500
| -29% | -$117K | ﹤0.01% | 1180 |
|
|
2021
Q2 | $518K | Sell |
8,500
-4,200
| -33% | -$256K | ﹤0.01% | 1036 |
|
|
2021
Q1 | $782K | Buy |
+12,700
| New | +$782K | 0.01% | 947 |
|